High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer

Breast Cancer Research and Treatment

Volumn 122, Issue 3, 2010, Pages 671-683

  Aceto, Gitana Maria ^a   Solano, Angela Rosaria ^b   Neuman, Maria Isabel ^b   Veschi, Serena ^a   Morgano, Annalisa ^a   Malatesta, Sara ^a   Chacon, Reinaldo Daniel ^c   Pupareli, Carmen ^c   Lombardi, Mercedes ^d   Battista, Pasquale ^a   Marchetti, Antonio ^a   Mariani Costantini, Renato ^a   Podestà, Ernesto Jorge ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUTO ALEXANDER FLEMING   (Argentina)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

BRCA1; BRCA2; Human papilloma virus; Juvenile breast cancer; Mutation; Reproductive factors; TP53

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN E6; PROTEIN P53; TAMOXIFEN; PRIMER DNA; TP53 PROTEIN, HUMAN; VIRUS DNA;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ETHNICITY; FANCONI ANEMIA; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; ONSET AGE; PAPILLOMAVIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCHOOL CHILD; TUMOR VOLUME; BREAST TUMOR; CASE REPORT; CHEMISTRY; ENZYME IMMUNOASSAY; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; OVARY TUMOR; PAGET NIPPLE DISEASE; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; RISK FACTOR; SECONDARY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHILD; DNA PRIMERS; DNA, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; IMMUNOENZYME TECHNIQUES; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREGNANCY; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77955557688     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0596-6     Document Type: Article

References (97)

1. DM Parkin 2004 International variation Oncogene 23 6329 6340 10.1038/sj.onc.1207726 1:CAS:528:DC%2BD2cXmvVOrtLY%3D 15322508 (Pubitemid 39272833)
2. PH Levine BG Pogo A Klouj S Coronel K Woodson SM Melana N Mourali JF Holland 2004 Increasing evidence for a human breast carcinoma virus with geographic differences Cancer 101 721 726 10.1002/cncr.20436 15305401 (Pubitemid 39030926)
3. A Tavani C Braga C La Vecchia E Negri A Russo S Franceschi 1997 Attributable risks for breast cancer in Italy: education, family history and reproductive and hormonal factors Int J Cancer 70 159 163 10.1002/(SICI)1097- 0215(19970117)70:2<159::AID-IJC4>3.0.CO;2-W 1:STN:280:DyaK2s7mt1WltQ%3D%3D 9009154 (Pubitemid 27107411)
4. DJ Hunter WC Willett 1993 Diet, body size, and breast cancer Epidemiol Rev 15 110 132 1:STN:280:DyaK2c%2FgvFeqtQ%3D%3D 8405195
5. BS Hulka PG Moorman 2001 Breast cancer: hormones and other risk factors Maturitas 38 103 113 10.1016/S0378-5122(00)00196-1 1:CAS:528: DC%2BD3MXislensro%3D 11311599 (Pubitemid 32304388)
6. RG Dumitrescu I Cotarla 2005 Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 9 208 221 10.1111/j.1582-4934.2005.tb00350.x 1:STN:280:DC%2BD2M7lt1Sjtw%3D%3D 15784178
7. YT Lagerros SF Hsieh CC Hsieh 2004 Physical activity in adolescence and young adulthood and breast cancer risk: a quantitative review Eur J Cancer Prev 13 5 12 10.1097/00008469-200402000-00002 1:STN:280:DC%2BD2c7otFOjuw%3D%3D 15075782 (Pubitemid 38328113)
8. LP Dehner DA Hill K Deschryver 1999 Pathology of the breast in children, adolescents, and young adults Semin Diagn Pathol 16 235 247 1:STN:280: DyaK1MvhvVOlsA%3D%3D 10490200
9. M Wilson ML Cranor PP Rosen 1993 Papillary duct hyperplasia of the breast in children and young women Mod Pathol 6 570 574 1:STN:280: DyaK2c%2FmvVeqtQ%3D%3D 8248114
10. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in 5 continents, vol. 8 (IARC Scientific Publication No. 155). International Agency for Research on Cancer (IARC), Lyon, France
11. D Medina 2005 Mammary developmental fate and breast cancer risk Endocr Relat Cancer 12 483 495 10.1677/erc.1.00804 1:CAS:528:DC%2BD2MXht1SjsrzO 16172188 (Pubitemid 41482989)
12. J Russo GA Balogh J Chen SV Fernandez R Fernbaugh R Heulings DA Mailo R Moral PA Russo F Sheriff JE Vanegas R Wang IH Russo 2006 The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention Front Biosci 11 151 172 10.2741/1788 1:CAS:528:DC%2BD2MXhtlSrur%2FE 16146722
13. IH Russo J Russo 1998 Role of hormones in mammary cancer initiation and progression J Mammary Gland Biol Neoplasia 3 49 61 10.1023/A:1018770218022 1:STN:280:DC%2BD3c3nslOqsw%3D%3D 10819504
14. Y Hiraku N Yamashita M Nishiguchi S Kawanishi 2001 Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation Int J Cancer 92 333 337 10.1002/ijc.1193 1:CAS:528:DC%2BD3MXjtVWitLc%3D 11291067 (Pubitemid 32249707)
15. L Hilakivi-Clarke S de Assis 2006 Fetal origins of breast cancer Trends Endocrinol Metab 17 340 348 10.1016/j.tem.2006.09.002 1:CAS:528: DC%2BD28XhtFWjurzL 16997567 (Pubitemid 44584730)
16. GA Brooks JE Stopfer J Erlichman R Davidson KL Nathanson SM Domchek 2006 Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic Cancer Biol Ther 5 1098 1102 16931905
17. Y Miki J Swensen D Shattuck-Eidens, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D 7545954 (Pubitemid 24345325)
18. R Wooster G Bignell J Lancaster S Swift S Seal J Mangion N Collins S Gregory C Gumbs G Micklem 1995 Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789 792 10.1038/378789a0 1:CAS:528:DyaK28XltFWi 8524414 (Pubitemid 26004412)
19. D Malkin FP Li LC Strong, et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1233 1238 10.1126/science.1978757 1:CAS:528:DyaK3MXjslSisw%3D%3D 1978757
20. F Lalloo J Varley A Moran D Ellis L O'Dair P Pharoah A Antoniou R Hartley A Shenton S Seal B Bulman A Howell D Gareth R Evans 2006 BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives Eur J Cancer 42 1143 1150 10.1016/j.ejca.2005.11.032 1:CAS:528: DC%2BD28Xks1erur8%3D 16644204
21. Y Liu VS Klimberg NR Andrews CR Hicks H Peng M Chiriva-Internati R Henry-Tillman 2001 Human papillomavirus DNA is present in a subset of unselected breast cancers J Hum Virol 4 329 334 1:CAS:528:DC%2BD38XlsF2mtLk%3D 12082399
22. JS Pagano M Blaser M Buendia B Da Mania K Khalili N Raab-Traub B Roizman 2004 Infectious agents and cancer: criteria for a causal relation Semin Cancer Biol 14 453 471 10.1016/j.semcancer.2004.06.009 1:CAS:528:DC%2BD2cXos1Kkt7Y%3D 15489139 (Pubitemid 39360994)
23. V Band D Zajchowski V Kulesa R Sager 1990 Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements Proc Natl Acad Sci USA 87 463 467 10.1073/pnas.87.1.463 1:CAS:528:DyaK3cXntlOitg%3D%3D 2153303 (Pubitemid 20033091)
24. AP Damin R Karam CG Zettler M Caleffi CO Alexandre 2004 Evidence for an association of human papillomavirus and breast carcinomas Breast Cancer Res Treat 84 131 137 10.1023/B:BREA.0000018411.89667.0d 1:CAS:528: DC%2BD2cXhslGju78%3D 14999143 (Pubitemid 38393363)
25. A Di Lonardo A Venuti ML Marcante 1992 Human papillomavirus in breast cancer Breast Cancer Res Treat 21 95 100 10.1007/BF01836955 1:STN:280: DyaK38zivF2ltQ%3D%3D 1320958
26. EM Hennig Z Suo S Thoresen R Holm S Kvinnsland JM Nesland 1999 Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III) Breast Cancer Res Treat 53 121 135 10.1023/A:1006162609420 1:STN:280:DyaK1M3ls1Ohsw%3D%3D 10326789 (Pubitemid 29161118)
27. N Muñoz S Franceschi C Bosetti V Moreno R Herrero JS Smith KV Shah CJ Meijer FX Bosch 2002 Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group Lancet 359 1093 1101 10.1016/S0140-6736(02)08151-5 11943256 (Pubitemid 34270732)
28. S Sethi M Müller A Schneider M Blettner E Smith L Turek J Wahrendorf L Gissmann J Chang-Claude 1998 Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women Am J Obstet Gynecol 178 360 364 10.1016/S0002-9378(98)80026-4 1:STN:280:DyaK1c7mtVWgtA%3D%3D 9500500 (Pubitemid 28124141)
29. G Schwartsmann 2001 Breast cancer in South America: challenges to improve early detection and medical management of a public health problem J Clin Oncol 19 18 Suppl 118S 124S 1:STN:280:DC%2BD3MrhtlSqug%3D%3D 11560986
30. Ellis IO, Schnitt SJ, Sastre-Garau X et al (2003) Invasive breast carcinoma. In: Tavassoli FA, Devilee P (eds) In pathology and genetics of the breast and female genital organs. IARC Press, Lyon, pp 13-59
31. Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
32. HF Frierson Jr RA Wolber KW Berean, et al. 1995 Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma Am J Clin Pathol 103 195 198 7856562
33. L Ottini G Masala C D'Amico B Mancini C Saieva G Aceto D Gestri V Vezzosi M Falchetti M De Marco M Paglierani A Cama S Bianchi R Mariani-Costantini D Palli 2003 BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy Cancer Res 63 342 347 1:CAS:528:DC%2BD3sXnt1KktA%3D%3D 12543786
34. T Soussi 2000 The p53 tumor suppressor gene: from molecular biology to clinical investigation Ann N Y Acad Sci 910 121 137 1:CAS:528: DC%2BD3cXlsVOjt74%3D 10911910
35. E Gross N Arnold K Pfeifer K Bandick M Kiechle 2000 Identification of specific BRCA1 and BRCA2 variants by DHPLC Hum Mutat 16 345 353 10.1002/1098-1004(200010)16:4<345::AID-HUMU7>3.0.CO;2-# 1:CAS:528:DC%2BD3cXnslCitb8%3D 11013445
36. T Wagner D Stoppa-Lyonnet E Fleischmann D Muhr S Pagès T Sandberg V Caux R Moeslinger G Langbauer A Borg P Oefner 1999 Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations Genomics 62 369 376 10.1006/geno.1999.6026 1:CAS:528:DC%2BD3cXls1enuw%3D%3D 10644434 (Pubitemid 30075166)
37. O Yamanoshita T Kubota J Hou, et al. 2005 DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues Int J Cancer 114 74 79 10.1002/ijc.20712 1:CAS:528:DC%2BD2MXhtFCns7g%3D 15523690 (Pubitemid 40194310)
38. PC Ng S Henikoff 2002 Accounting for human polymorphisms predicted to affect protein function Genome Res 12 436 446 10.1101/gr.212802 1:CAS:528:DC%2BD38XitFSltLg%3D 11875032 (Pubitemid 34233019)
39. L Cartegni J Wang Z Zhu MQ Zhang AR Krainer 2003 ESEfinder: A web resource to identify exonic splicing enhancers Nucleic Acids Res 31 3568 3571 10.1093/nar/gkg616 1:CAS:528:DC%2BD3sXltVWisLw%3D 12824367 (Pubitemid 37442199)
40. L Ottini D Palli M Falchetti C D'Amico A Amorosi C Saieva A Calzolari F Cimoli C Tatarelli L De Marchis G Masala R Mariani-Costantini A Cama 1997 Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany Cancer Res 57 4523 4529 1:CAS:528:DyaK2sXmslKqt7g%3D 9377564
41. M Mahdavinia F Bishehsari F Verginelli A Cumashi R Lattanzio M Sotoudeh R Ansari D Semeraro M Hormazdi H Fakheri N Rakhshani L De Lellis MC Curia A Cama M Piantelli R Malekzadeh S Iacobelli R Mariani-Costantini 2008 P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations J Cell Physiol 216 543 550 10.1002/jcp.21428 1:CAS:528:DC%2BD1cXotFyrtbo%3D 18330889 (Pubitemid 351898483)
42. BJ Morris 2005 Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region Clin Chem Lab Med 43 1171 1177 10.1515/CCLM.2005.203 1:CAS:528:DC%2BD2MXht12ntLrO 16232081 (Pubitemid 41600666)
43. T Sørlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lønning PO Brown AL Børresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
44. MN Aoki AC da Silva do Amaral Herrera MK Amarante JL do Val Carneiro MH Fungaro MA Watanabe 2009 CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development Int J Mol Med 23 429 435 1:CAS:528: DC%2BD1MXjs1Khs7w%3D 19212663
45. ME Scheurer G Tortolero-Luna K Adler-Storthz 2005 Human papillomavirus infection: biology, epidemiology, and prevention Int J Gynecol Cancer 15 727 746 10.1111/j.1525-1438.2005.00246.x 1:STN:280:DC%2BD2Mrgt1Kltw%3D%3D 16174218 (Pubitemid 41783075)
46. MH Stoler 2000 Human papillomaviruses and cervical neoplasia: a model for carcinogenesis Int J Gynecol Pathol 19 16 28 10.1097/00004347-200001000-00004 1:STN:280:DC%2BD3c7gtlyjtw%3D%3D 10638450
47. R Klaes T Friedrich D Spitkovsky R Ridder W Rudy U Petry G Dallenbach-Hellweg D Schmidt M von Knebel Doeberitz 2001 Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 276 284 10.1002/ijc.1174 1:CAS:528:DC%2BD3MXivVKqurw%3D 11291057 (Pubitemid 32225381)
48. F Luft R Klaes M Nees M Dürst V Heilmann P Melsheimer M von Knebel Doeberitz 2001 Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells Int J Cancer 92 9 17 10.1002/1097-0215(200102)9999:9999<::AID- IJC1144>3.0.CO;2-L 1:CAS:528:DC%2BD3MXitVGqtrc%3D 11279600
49. N Wentzensen S Vinokurova M von Knebel Doeberitz 2004 Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract Cancer Res 64 3878 3884 10.1158/0008-5472.CAN-04-0009 1:CAS:528:DC%2BD2cXksVKnsr0%3D 15172997 (Pubitemid 38697299)
50. H Kuroda G Sakamoto K Ohnisi S Itoyama 2005 Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast Breast Cancer 12 189 195 10.2325/jbcs.12.189 16110288
51. A Nonomura A Kimura Y Mizukami S Nakamura K Ohmura Y Watanabe K Tanimoto S Ikegaki 1995 Secretory carcinoma of the breast associated with juvenile papillomatosis in a 12-year-old girl. A case report Acta Cytol 39 569 576 1:STN:280:DyaK2M3ot1Gksw%3D%3D 7762355
52. HE Rice A Acosta RL Brown C Gutierrez M Alashari D Mintequi A Rodriguez O Chavarrfa RG Azizkhan 2000 Juvenile papillomatosis of the breast in male infants: two case reports Pediatr Surg Int 16 104 106 10.1007/s003830050030 1:STN:280:DC%2BD3c7jtV2rtQ%3D%3D 10663852
53. Rosen PP (1997) Rosen's breast pathology. Lippincott-Raven Publishers, Philadelphia, pp 441-447
54. T Sano T Oyama K Kashiwabara T Fukuda T Nakajima 1998 Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am J Pathol 153 1741 1748 1:CAS:528: DyaK1cXotV2ku78%3D 9846965
55. D Ford DF Easton M Stratton, et al. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676 689 10.1086/301749 1:CAS:528:DyaK1MXlvFeh 9497246 (Pubitemid 28164626)
56. MR McClain KL Nathanson GE Palomaki JE Haddow 2005 An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women Genet Med 7 34 39 10.1097/01.GIM.0000151156.14983.08 1:CAS:528:DC%2BD2MXkvFWguw%3D%3D 15654226 (Pubitemid 40111129)
57. S Veschi G Aceto AP Scioletti V Gatta G Palka A Cama R Mariani-Costantini P Battista V Calò F Barbera V Bazan A Russo L Stuppia 2007 High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability Ann Oncol 18 Suppl 6 vi86 vi92 10.1093/annonc/mdm233 17591842
58. J Palacios MJ Robles-Frías MA Castilla MA López- García J Benítez 2008 The molecular pathology of hereditary breast cancer Pathobiology 75 85 94 10.1159/000123846 1:STN:280:DC%2BD1czns1yjug%3D%3D 18544963 (Pubitemid 351820726)
59. K Offit O Levran B Mullaney K Mah K Nafa SD Batish R Diotti H Schneider A Deffenbaugh T Scholl VK Proud M Robson L Norton N Ellis H Hanenberg AD Auerbach 2003 Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia J Natl Cancer Inst 95 1548 1551 1:CAS:528:DC%2BD3sXosVertbk%3D 14559878
60. SA Narod 2006 Modifiers of risk of hereditary breast cancer Oncogene 25 5832 5836 10.1038/sj.onc.1209870 1:CAS:528:DC%2BD28XhtVSgurvK 16998497 (Pubitemid 44453438)
61. E Lee H Ma R McKean-Cowdin D Van Den Berg L Bernstein BE Henderson G Ursin 2008 Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study Cancer Epidemiol Biomarkers Prev 17 3170 3178 10.1158/1055-9965.EPI-08-0396 1:CAS:528:DC%2BD1cXhtlCkurzN 18990759
62. N Andrieu DE Goldgar DF Easton, et al. 2006 Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) J Natl Cancer Inst 98 535 544 10.1093/jnci/djj132 16622123 (Pubitemid 43898817)
63. L Keinan-Boker L Lerner-Geva B Kaufman D Meirow 2008 Pregnancy-associated breast cancer Isr Med Assoc J 10 722 727 19009954
64. KD Awadelkarim G Aceto S Veschi A Elhaj A Morgano AA Mohamedani EA Eltayeb D Abuidris M Di Gioacchino P Battista F Verginelli A Cama NE Elwali R Mariani-Costantini 2007 BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors Breast Cancer Res Treat 102 189 199 10.1007/s10549-006-9303-z 1:CAS:528:DC%2BD2sXjt1Kqurc%3D 17333343 (Pubitemid 46452165)
65. GJ Matlashewski S Tuck D Pim P Lamb J Schneider LV Crawford 1987 Primary structure polymorphism at amino acid residue 72 of human p53 Mol Cell Biol 7 961 963 1:CAS:528:DyaL2sXhtlarsLo%3D 3547088
66. D Pim L Banks 2004 p53 polymorphic variants at codon 72 exert different effects on cell cycle progression Int J Cancer 108 196 199 10.1002/ijc.11548 1:CAS:528:DC%2BD3sXhtVWgu7zI 14639602 (Pubitemid 37541770)
67. P Dumont JI Leu AC Della Pietra III DL George M Murphy 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357 365 10.1038/ng1093 1:CAS:528:DC%2BD3sXhsV2ktbc%3D 12567188 (Pubitemid 36278852)
68. S Katiyar BK Thelma NS Murthy S Hedau N Jain V Gopalkrishna SA Husain BC Das 2003 Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India Mol Cell Biochem 252 117 124 10.1023/A:1025546610920 1:CAS:528:DC%2BD3sXmvFeqsro%3D 14577584 (Pubitemid 37220740)
69. MM Siddique C Balram L Fiszer-Maliszewska A Aggarwal A Tan P Tan KC Soo K Sabapathy 2005 Evidence for selective expression of the p53 codon 72 polymorphism: implications in cancer development Cancer Epidemiol Biomarkers Prev 14 2245 2252 10.1158/1055-9965.EPI-05-0153 1:CAS:528:DC%2BD2MXhtVWgtbvN 16172238 (Pubitemid 41603274)
70. M Olivier A Langerød P Carrieri J Bergh S Klaar J Eyfjord C Theillet C Rodriguez R Lidereau I Bièche J Varley Y Bignon N Uhrhammer R Winqvist A Jukkola-Vuorinen D Niederacher S Kato C Ishioka P Hainaut AL Børresen-Dale 2006 The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer Clin Cancer Res 12 1157 1167 10.1158/1078-0432.CCR-05-1029 1:CAS:528:DC%2BD28XhsFalt7Y%3D 16489069 (Pubitemid 43342504)
71. N Muñoz X Castellsague AB de Gonzalez L Gissman 2006 HPV in the etiology of human cancer Vaccine 24 S1 S10 10.1016/j.vaccine.2006.05.115 (Pubitemid 44293019)
72. S Jeon PF Lambert 1995 Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis Proc Natl Acad Sci USA 92 1654 1658 10.1073/pnas.92.5.1654 1:CAS:528:DyaK2MXktFWrsrs%3D 7878034
73. S Vinokurova N Wentzensen J Einenkel R Klaes C Ziegert P Melsheimer H Sartor LC Horn M Höckel M von Knebel Doeberitz 2005 Clonal history of papillomavirus-induced dysplasia in the female lower genital tract J Natl Cancer Inst 97 1816 1821 10.1093/jnci/dji428 1:CAS:528:DC%2BD2MXhtlCmsbfP 16368943 (Pubitemid 43033902)
74. International Agency for Research on Cancer (IARC) (1995) IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 64. IARC, Lyon
75. N Ganguly SP Parihar 2009 Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis J Biosci 34 113 123 10.1007/s12038-009-0013-7 1:CAS:528:DC%2BD1MXkvFenu7g%3D 19430123 Review
76. CB Woodman SI Collins LS Young 2007 The natural history of cervical HPV infection: unresolved issues Nat Rev Cancer 7 11 22 10.1038/nrc2050 1:CAS:528:DC%2BD28XhtlCht7bN 17186016 (Pubitemid 46020844)
77. C Kroupis A Markou N Vourlidis A Dionyssiou-Asteriou ES Lianidou 2006 Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics Clin Biochem 39 727 731 10.1016/j.clinbiochem.2006.03.005 1:CAS:528:DC%2BD28XntVWitro%3D 16780823 (Pubitemid 44036781)
78. W Pornthanakasem K Shotelersuk W Termrungruanglert N Voravud S Niruthisard A Mutirangura 2001 Human papillomavirus DNA in plasma of patients with cervical cancer BMC Cancer 1 2 10.1186/1471-2407-1-2 1:STN:280: DC%2BD38votFyltQ%3D%3D 11244579 (Pubitemid 38851282)
79. B Samama D Lipsker N Boehm 2006 p16 expression in relation to human papillomavirus in anogenital lesions Hum Pathol 37 513 519 10.1016/j.humpath. 2006.01.001 1:CAS:528:DC%2BD28XktVOru7g%3D 16647947
80. I Nindl T Meyer T Schmook C Ulrich R Ridder H Audring W Sterry E Stockfleth 2004 Human papillomavirus and overexpression of P16INK4a in nonmelanoma skin cancer Dermatol Surg 30 409 414 10.1111/j.1524-4725.2004.30111. x 15008871 (Pubitemid 38524162)
81. HC Hafkamp EJ Speel A Haesevoets FJ Bot WN Dinjens FC Ramaekers AH Hopman JJ Manni 2003 A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8 Int J Cancer 107 394 400 10.1002/ijc.11389 1:CAS:528:DC%2BD3sXos1Gns7k%3D 14506739 (Pubitemid 37266459)
82. JP Klussmann E Gültekin SJ Weissenborn U Wieland V Dries HP Dienes HE Eckel HJ Pfister PG Fuchs 2003 Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus Am J Pathol 162 747 753 1:CAS:528:DC%2BD3sXit1Gks70%3D 12598309
83. A Shai HC Pitot PF Lambert 2008 p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers Cancer Res 68 2622 2631 10.1158/0008-5472.CAN-07-5266 1:CAS:528:DC%2BD1cXks1GitLo%3D 18413729 (Pubitemid 351556259)
84. IN Mammas G Sourvinos DA Spandidos 2009 Human papilloma virus (HPV) infection in children and adolescents Eur J Pediatr 168 267 273 10.1007/s00431-008-0882-z 19050916
85. AP Subhawong T Subhawong H Nassar N Kouprina S Begum R Vang WH Westra P Argani 2009 Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically Am J Surg Pathol 33 163 175 10.1097/PAS.0b013e31817f9790 18936692
86. JI Herschkowitz X He C Fan CM Perou 2008 The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas Breast Cancer Res 10 R75 10.1186/bcr2142 18782450
87. M Derenzini G Donati G Mazzini L Montanaro M Vici C Ceccarelli D Santini M Taffurelli D Treré 2008 Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure Clin Cancer Res 14 2199 2209 10.1158/1078-0432.CCR-07-2065 1:CAS:528: DC%2BD1cXkt1arsrs%3D 18381962 (Pubitemid 351551133)
88. M Derenzini E Brighenti G Donati M Vici C Ceccarelli D Santini M Taffurelli L Montanaro D Treré 2009 The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein J Pathol 219 3 373 382 10.1002/path.2612 1:CAS:528:DC%2BD1MXhsVOgsrbP 19731257
89. P Lassen JG Eriksen S Hamilton-Dutoit T Tramm J Alsner J Overgaard 2009 Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 1992 1998 10.1200/JCO.2008.20.2853 1:CAS:528:DC%2BD1MXls1CgtLo%3D 19289615
90. JP Klussmann JJ Mooren M Lehnen SM Claessen M Stenner CU Huebbers SJ Weissenborn I Wedemeyer SF Preuss JM Straetmans JJ Manni AH Hopman EJ Speel 2009 Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications Clin Cancer Res 15 1779 1786 10.1158/1078-0432. CCR-08-1463 1:CAS:528:DC%2BD1MXisVWrsL4%3D 19223504
91. M Beglin M Melar-New L Laimins 2009 Human papillomaviruses and the interferon response J Interferon Cytokine Res 29 629 635 10.1089/jir.2009.0075 1:CAS:528:DC%2BD1MXhtFalu7vJ 19715460
92. RJ Critchley-Thorne DL Simons N Yan AK Miyahira FM Dirbas DL Johnson SM Swetter RW Carlson GA Fisher A Koong S Holmes PP Lee 2009 Impaired interferon signaling is a common immune defect in human cancer Proc Natl Acad Sci USA 106 9010 9015 10.1073/pnas.0901329106 1:CAS:528:DC%2BD1MXntlyiu7Y%3D 19451644
93. M Stanley 2003 Genital human papillomavirus infections-current and prospective therapies J Natl Cancer Inst Monographs 31 117 124 12807955
94. CL Trimble IH Frazer 2009 Development of therapeutic HPV vaccines Lancet Oncol 10 975 980 10.1016/S1470-2045(09)70227-X 1:CAS:528:DC%2BD1MXhtFOqurnI 19796749
95. AE Albers AM Kaufmann 2009 Therapeutic human papillomavirus vaccination Public Health Genomics 12 331 342 10.1159/000214923 19684445
96. B Heng WK Glenn Y Ye B Tran W Delprado L Lutze-Mann NJ Whitaker JS Lawson 2009 Human papilloma virus is associated with breast cancer Br J Cancer 101 1345 1350 10.1038/sj.bjc.6605282 1:CAS:528:DC%2BD1MXht1Gnur7I 19724278
97. DR Lowy D Solomon A Hildesheim JT Schiller M Schiffman 2008 Human papillomavirus infection and the primary and secondary prevention of cervical cancer Cancer 113 7 Suppl 1980 1993 10.1002/cncr.23704 18798536